BIRCH GROVE CAPITAL LP
Q1 2024 Form 13-F
NEW YORK, NEW YORK
CIK 0001652355
· CRD 168245
· SEC-registered investment adviser
$13.1M Reported Value Total
BIRCH GROVE CAPITAL LP reports 28 total accounts under management (AUM). There are 28 discretionary accounts valued at $6,039,446,782, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered
Exempt Reporting Adviser
Discretionary Manager
Private funds (Form ADV)
12 funds
· $4.8B gross asset value
Securitized Asset Fund: $3.6B · Hedge Fund: $1.1B · Private Equity Fund: $0
Source: Form ADV filed 2024-12-11
Reported value
$13.1M
Quarter over quarter
+4.1%
Holdings
2
Top-10 concentration
100.0%
Key People
Form ADV owners & control persons
Jonathan Israel Berger
LIMITED PARTNER
Andrew Adam Fink
LIMITED PARTNER
Todd Andrew Berry
CHIEF OPERATING OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2024 13F record
Q1 2024 13F filing summary
| Period of report | March 31, 2024 |
|---|---|
| Filed | May 15, 2024 |
| Form | 13F-HR |
| Reported value | $13.1M |
| Positions | 2 |
| Change in reported value | -43.8% |
| New positions | 0 |
| Exited positions | 3 |
| Position turnover | 60.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2024 13F
Filed Nov 14, 2024
|
0 | $9.5M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
1 | $10.0M |
|
Q1 2024 13F
Filed May 15, 2024
|
2 | $13.1M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
4 | $23.3M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
5 | $57.4M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
6 | $68.1M |
|
Q1 2023 13F
Filed May 15, 2023
|
6 | $110.4M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
10 | $210.1M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
12 | $256.2M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
13 | $251.9M |
|
Q1 2022 13F
Filed May 17, 2022
|
15 | $244.8M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
21 | $220.9M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
21 | $212.2M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
22 | $205.8M |
|
Q1 2021 13F
Filed May 17, 2021
|
28 | $230.4M |
|
Q4 2020 13F
Filed Feb 16, 2021
|
25 | $191.7M |
|
Q3 2020 13F
Filed Nov 16, 2020
|
31 | $184.6M |
|
Q2 2020 13F
Filed Aug 14, 2020
|
22 | $120.6M |
|
Q1 2020 13F
Filed May 15, 2020
|
5 | $69.9M |
|
Q4 2019 13F
Filed Feb 14, 2020
|
4 | $80.7M |
16 earlier quarters on file — choose one from the quarter menu above.
Top 6 holdings · Q1 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | MITK 0.75 02/01/26 MITEK SYS INC | $8.7M | 66.61% |
| 2 | KPTI 3 10/15/25 KARYOPHARM THERAPEUTICS INC | $3.2M | 24.49% |
| 3 | REAL 1 03/01/28 THE REALREAL INC | $1.1M | 8.59% |
| 4 | CVIIW CHURCHILL CAPITAL CORP VII | $24.5K | 0.19% |
| 5 | SPY P SPDR S&P 500 ETF TR | $9.2K | 0.07% |
| 6 | MPLNWS MULTIPLAN CORPORATION | $7.5K | 0.06% |
Values as reported on the Q1 2024 Form 13F. Every position is in the holdings table below.